XT
CRNX

XTX Topco’s Crinetics Pharmaceuticals CRNX Stock Holding History

XTX Topco’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.16M Buy
111,292
+14,126
+15% +$525K 0.05% 486
2026
Q1 		$3.53M Buy
+97,166
New +$4.34M 0.06% 462
2025
Q3 		– Sell
-34,013
Closed -$978K – 2682
2025
Q2 		$978K Buy
+34,013
New +$1.05M 0.04% 681

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's CRNX Position: Q2 2026 in Review

XTX Topco increased its Crinetics Pharmaceuticals (CRNX) stake by 15% in Q2 2026, buying an estimated $525K and bringing the position to 111,292 shares worth $4.16M. The position accounts for 0.05% of the portfolio, ranked #486.

XTX Topco first reported a position in CRNX in Q2 2025 and has held it in 3 quarters since. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • XTX Topco held 111,292 shares of Crinetics Pharmaceuticals worth $4.16M as of Q2 2026.
  • XTX Topco bought 14,126 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $525K.
  • Crinetics Pharmaceuticals made up 0.05% of XTX Topco's portfolio in Q2 2026, its #486 holding.
  • XTX Topco first reported a position in Crinetics Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.